Current therapeutic approaches to cardio-protection in hypertension

David Parra1, Augustus Hough

  • 1Section of Clinical Pharmacy, Veterans Affairs Medical Center West Palm Beach, 7305 North Military Trail, West Palm Beach, FL, 33410, USA, David.Parra@va.gov.

Insights

New hypertension guidelines offer improved blood pressure measurement techniques and re-evaluated targets. These advancements aim to further reduce cardiovascular risk in hypertensive patients through updated therapeutic strategies.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Preventive Medicine

Background:

  • Current hypertension management focuses on risk-based blood pressure targets and stepwise pharmacotherapy.
  • Traditional approaches involve drug selection based on compelling indications and titration to achieve target blood pressure.
  • The established methods have been instrumental in reducing cardiovascular risk in patients with hypertension.

Purpose of the Study:

  • To review emerging evidence on blood pressure measurement.
  • To discuss re-evaluated blood pressure targets for hypertension.
  • To explore novel therapeutic strategies for cardiovascular risk reduction.

Main Methods:

  • Literature review of recent advancements in blood pressure monitoring.
  • Analysis of updated clinical guidelines and research on hypertension targets.
  • Synthesis of new therapeutic approaches in hypertension management.

Main Results:

  • Improved accuracy and accessibility in blood pressure measurement techniques are now available.
  • Re-evaluation suggests potentially lower or more individualized blood pressure targets.
  • Emerging therapies offer additional avenues for cardiovascular risk mitigation.

Conclusions:

  • Recent advancements in blood pressure measurement and target re-evaluation present opportunities for enhanced hypertension care.
  • Integrating these new findings into clinical practice may lead to superior cardiovascular risk reduction.
  • A paradigm shift towards more precise and personalized hypertension management is indicated.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.7K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
992
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
621
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
750
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
688